Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus
Clinical trial NCT00913367 · COMPLETED
Trial details
- NCT number
- NCT00913367
- Sponsor
- Handok Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2010-11-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.